18.11
-0.78
(-4.13%)
At close: January 10 at 3:58:59 PM GMT+5:30
Breakdown
TTM
3/31/2024
3/31/2023
3/31/2022
3/31/2021
Operating Cash Flow
-50,558.00
-59,583.00
105,293.00
163,290.00
-20,631.00
Investing Cash Flow
730,011.00
830,196.00
-449,527.00
-270,733.00
-753,533.00
Financing Cash Flow
-678,663.00
-145,576.00
350,014.00
82,945.00
719,604.00
End Cash Position
2,503.00
633,834.00
8,797.00
3,017.00
27,514.00
Capital Expenditure
-39,751.00
-81,364.00
-206,347.00
-113,129.00
-26,557.00
Issuance of Capital Stock
--
--
145,788.00
136,302.00
121,060.00
Free Cash Flow
-90,309.00
-140,947.00
-101,054.00
50,161.00
-47,188.00
3/31/2021 - 12/31/2001
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
JENBURPH.BO Jenburkt Pharmaceuticals Limited
1,277.55
+4.03%
THEMISMED.NS Themis Medicare Limited
260.65
-3.91%
GLAND.BO Gland Pharma Limited
1,784.35
-2.35%
MOREPENLAB.NS Morepen Laboratories Limited
68.23
-3.75%
NATCOPHARM.NS NATCO Pharma Limited
1,235.55
-4.09%
DRREDDY.NS Dr. Reddy's Laboratories Limited
1,354.40
-1.25%